On Tuesday, Shares of Novavax, Inc. (NASDAQ:NVAX), added 3.92% and closed at $1.59 in the last trading session. NVAX stock opened its last trade at $1.50 and after floating in a range of $1.50 to $1.63. The company’s Market capitalization is $422.90 million with the total Outstanding Shares of 271.19 million. During the 52-week trading session the minimum price at which share price traded, registered at $1.16 and reached to max level of $9.23. The Earnings per Share of the company stands at $-0.99. Novavax, Inc., (NVAX) recently declared it has replanned its 4th annual Shareholder and Analyst Meeting. The Company will host an Shareholder and Analyst update as part of its third quarter financial results conference call and webcast on Wednesday, November 9, 2016.
“We continue to analyze data from our Resolve clinical trial and map out the clinical path forward for our older adult RSV F Vaccine in the context of our other clinical programs,” said Stanley C. Erck, President and CEO. “We would like to finalize those plans and communicate them at the same time as our third quarter financial results call in early November. We look forward to providing the next steps in our RSV F Vaccine program, in addition to an update on the path forward for additional programs in our pipeline and our financial and operating plan, which we will provide as a dedicated part of our November financial results.”
Shares of Invesco Ltd. (NYSE:IVZ), gained 0.07% and closed at $29.59 in the last trading session. IVZ stock opened its last trade at $30.00 and after floating in a range of $29.52 to $30.00. The company’s Market capitalization is $11.99 Billion with the total Outstanding Shares of 400.40 million. During the 52-week trading session the minimum price at which share price traded, registered at $23.01 and reached to max level of $35.00. The Earnings per Share of the company stands at $1.99. Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client-focused equity and fixed income portfolios. The firm also launches equity, fixed income, commodity, multi-asset, and balanced mutual funds for its clients. It launches equity, fixed income, multi-asset, and balanced exchange-traded funds. The firm also launches and manages private funds. It invests in the public equity and fixed income markets across the globe. The firm also invests in alternative markets, such as commodities and currencies. For the equity portion of its portfolio, it invests in growth and value stocks of large-cap, mid-cap, and small-cap companies. For the fixed income portion of its portfolio, the firm invests in convertibles, government bonds, municipal bonds, treasury securities, and cash. It also invests in short term and intermediate term bonds, investment grade and high yield bonds, taxable and tax-free bonds, senior secured loans, and structured securities such as asset-backed securities, mortgage-backed securities, and commercial mortgage-backed securities. The firm employs absolute return, global macro, and long/short strategies.